[West Nile meningoencephalitis in an immunocompromised patient]

Rev Neurol (Paris). 2008 Dec;164(12 Suppl):F275-9. doi: 10.1016/S0035-3787(08)75128-2.
[Article in French]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Coma / etiology
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Dopamine Agents / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Fatal Outcome
  • Humans
  • Immunocompromised Host
  • Immunoglobulin G / immunology
  • Immunoglobulin M / analysis
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / immunology
  • Levodopa / therapeutic use
  • Magnetic Resonance Imaging
  • Male
  • Meningoencephalitis / immunology
  • Meningoencephalitis / pathology*
  • Meningoencephalitis / virology
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Prednisolone / therapeutic use
  • Reverse Transcriptase Polymerase Chain Reaction
  • West Nile Fever / immunology
  • West Nile Fever / pathology*
  • West Nile Fever / virology
  • West Nile virus / genetics
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Dopamine Agents
  • Immunoglobulin G
  • Immunoglobulin M
  • Immunosuppressive Agents
  • Levodopa
  • Cyclosporine
  • Prednisolone
  • Mycophenolic Acid